Technology

As technology improves, less-invasive treatments save patients time and money.

Brandon Barber, chief marketing officer at Heru, shares about the company's new dark adaptation modality, which they announced during the 2022 Vision Expo West, as well as other advancements in the pipeline.

Valerie M. Kattouf, OD, discusses going back to the basics of neuro-ophthalmology + managing vision and visual-motor abnormalities in patients.

With the launch of dark adaptation, Heru is now the only platform on the AMD market to include contrast sensitivity and dark adaptation exams.

Low prediction errors from 2 evaluated formulas shows promise for accurate prediction of IOL formulas in high myopic patients.

Leo P. Semes, OD, FAAO, highlights his presentation on "Artificial intelligence and telemedicine," presented during the 115th annual SCOPA meeting.

Establish a program in your practice during this Wild West phase of tech.

Results from a parallel arm study suggest opportunity to expand on visual performance and productivity improvement.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part four.

Advancements enable better diagnosis, treatment of patients.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part two.

The company intends to develop the AcuStream technology for potential use with its current and future front-of-eye therapies, which may include lifitegrast ophthalmic solution for the treatment of dry eye disease.

Mojo Vision's CEO Drew Perkins announced last week that he became the first, and currently only, person to wear the latest prototype of Mojo Lens, an augmented reality-based contact lens.

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part one.

Knowing your glaucoma vitals is key to providing best treatment for patients.

Embracing this new model of care can allow optometric practices to flourish—and may enable earlier detection of conversion from intermediate dry to wet AMD.

The amount of light effused by these round-shaped eyeglass frames are designed to match the exact wavelength of sunlight a user would be exposed to outside.

The company's technology allows for ECPs to detect, monitor, and treat AMD 3 years before clinical diagnosis.

A prototype of a visually-guided hearing aid (VGHA) designed at Boston University of a the formed beam is manipulated by eye gaze to improve the ability of users of the technology to better focus on one sound despite the presence of nearby competing sounds.

Optimizing eye care for pilots is crucial for safe flying.

Advice for pilots to consider ahead of taking flight.

Wearable devices and multifunctional instruments provide in-office advantages

As an all-in-one handheld device, eyecare practitioners can tailor patients’ needs for MGD treatment in both eyes in approximately 8 to 12 minutes.

Heru Chief Marketing Officer Brandon Barber speaks on the company's upcoming advancements and two new testing modalities on its diagnostic platform: Fast Pattern Suprathreshold Visual Field and the Farnsworth D-15 extended color vision exam.

Education, advancing technology are key to meeting patient needs

With its portable capabilities, the Heru platform replaces legacy diagnostic devices and surpasses standard care in cost and size.

Breakthrough film technology stops lenses from fogging faster than the blink of an eye

The company expects to enroll patients diagnosed with keratoconus in two trials at clinical sites in the US, South America, Europe, and Asia.

The new anti-reflective lens coating outperforms its predecessors by up to 70%